The INDEPTH TB network a research collaboration on. Christian Wejse Bandim Health Project, Guinea Bissau / Aarhus University, Denmark

Similar documents
WG: Vaccinations and child survival Focus:

DIABETES PREVALENCE IN TB PATIENTS, TB SUSPECTS AND HEALTHY CONTROLS

Better Health Information for Better Health Policy

Prevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials

INDEPTH Network. Delivering Better Health Information Driving Better Health Policy THE PAST, THE PRESENT & THE FUTURE

22-26 September 2008 White Sands Hotel, Dar es Salaam, Tanzania

INDEPTH SCIENTIFIC CONFERENCE PROGRAMME

TB Disease Prevalence Survey - Progress Report

YEAR SITE BECAME INDEPTH MEMBER. South Africa University of KwaZulu- Natal

Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi:

Estimating TB burden. Philippe Glaziou World Health Organization Accra, Ghana

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

The KEMRI/CDC Health & Demographic Surveillance System

SURVEY FINDINGS April 28, 2017

TRANSLATING RESEARCH INTO POLICY AND PRACTICE - Examples from HDSS Centres

TB Disease Prevalence Survey - Overview and Introduction of the TF

Monitoring top 10 indicators. Philippe Glaziou September 2016

511,000 (57% new cases) ~50,000 ~30,000

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

Qian Gao Fudan University

The first National TB Prevalence Survey Rwanda 2012

The human immunodeficiency virus/acquired immune

Analysis of Coverage of Fully Immunized Child (FIC), Associated Factors, Outcomes, and Impact Using Routinely Collected Population Cohort Data

Ethiopia. Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT

Status of RTS,S/AS01 malaria vaccine candidate

Overview of the Presentation

TB Infection Control Policy. Scaling-up the implementation of collaborative TB/HIV activities in the Region of the

The New WHO guidelines on intensified TB case finding and Isoniazid preventive therapy and operational considerations

The National TB Prevalence Survey Pakistan

INDEPTH NETWORK ANNUAL REPORT

Ongoing Research on LTBI and Research priorities in India

Developing TB Vaccine Clinical Trial Capacity Aeras Perspective. Vicky Cardenas, PhD, JD

TB Disease Prevalence Survey - Overview, why and how

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

Tuberculosis in children: gaps and opportunities

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

National TB prevalence surveys

Safety of Oral Pentavalent Rotavirus Vaccine in Kenya, Including Among HIV-Infected Infants

Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar

TB Prevalence Survey. -Census, Interview and X ray- Ikushi Onozaki MD, MPH STB, WHO Geneva

Controlling TB in the era of HIV

Virtual Implementation Evaluation of Tuberculosis diagnostics in Tanzania Ivor Langley, Liverpool School of Tropical Medicine

STUDENT MEDICAL FORM

CDC's Tuberculosis Trials Consortium

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

7.5 South-East Asian Region: summary of planned activities, impact and costs

Age-Sex Structure for Selected African countries in the early 2000s

Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Against intervention No recommendation Strong Conditional Conditional Strong. For intervention. High Moderate Low Very low

Algorithmic Approaches to Child TB Management in Resource-limited Settings

Vaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA

Active case finding. Care Pathways: Seek Find Follow

La Lotta alla Tubercolosi. Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland. Geneva March 2012

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007

Responding to a TB Event Bismarck, North Dakota June 24-25, 2008

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

New vaccine technologies: Promising advances may save more lives

IPT IMPLEMENTATION- SWAZILAND EXPERIENCE

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

O c t o b e r 1 0,

Photo : Sylvie Ricard. The state of TB in Nunavik

Evolving Realities of HIV Treatment in Resource-limited Settings

CDC s Commitment to National Laboratory Systems to Achieve Global Health Security

Update on the 2007 TB Technical Instructions. Adriene Rister TB Control Coordinator Mainely TB: April 14, 2011

EBOLA SITUATION REPORT

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Contact Investigation and Prevention in the USA

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine

Kenya Perspectives. Post-2015 Development Agenda. Tuberculosis

Barriers to Global TB Control. Carol D. Hamilton, MD, MHS Director, Scientific Affairs FHI 360 Professor of Medicine, Duke University

Pharmacovigilance BMGF Perspective. Raj Long Bill & Melinda Gates Foundation

Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority?

Studies of Epilepsy Epidemiology in Demographic Sites (SEEDS) Kenya Medical Research Institute/WellcomeTrust Kilifi, Kenya INDEPTH SEEDS Group

HPTN 052. Myron S. Cohen, MD Principal Investigator. Presented at the 6 th Int. Workshop on HIV Transmission, July 2011, Rome, Italy

HIV Clinicians Society Conference TB/HIV Treatment Cascade

"GUARDING AGAINST TUBERCULOSIS IN HEALTHCARE FACILITIES"

Systematic review of epidemiological evidence

SOUTH AFRICA S TB BURDEN - OVERVIEW

NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016

Successes and remaining barriers to routine TB screening and implementation of IPT in Cambodia

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks

Global reductions in measles mortality and the risk of measles resurgence

Kaya HDSS, Burkina Faso

HIV/AIDS and Nutrition Programming in ACF International Network

Call to Action To Accelerate Access to DR-TB Drugs: 2016 Update

DETERMINANTS OF DELAY IN THE DIAGNOSIS AND TREATMENT OF SUSPECTED TUBERCULOSIS BY HIV STATUS IN SOUTH AFRICA. Victor Kanje

Implications of beneficial off-target effects for upcoming eradication campaigns (measles and polio)

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)

Data Use to Inform HIV Programs and Policies. Usma Khan, MS Hilary Spindler, MPH Prevention and Public Health Group Global Health Sciences

The Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer

Next Generation TB Diagnostics An Update from BMGF. Lee Pyne-Mercier

"GUARDING AGAINST TUBERCULOSIS AS A FIRST RESPONDER"

Helping TB patients quit smoking: the potential impact, WHO recommendations and country experience

Appendix 3 Sample size and cost of surveys

TB/HIV prevention. Implementation science and TB prevention

Lessons learned from the IeDEA West Africa Collaboration

The Western Pacific Region faces significant

Transcription:

The INDEPTH TB network a research collaboration on TB suspects and risk factors Christian Wejse Bandim Health Project, Guinea Bissau / Aarhus University, Denmark

History 2008: Osman shared a vision that INDEPTH would also contain a vibrant cross-site TB research arm 2009: The secretariat facilitated initial consultations and establishment of a TB interest group of sites to meet in Bissau

History 2010: First meeting of the TB working group, participating sites: Ballabgarh, India Bandim, Guinea Bissau Dodalab, Vietnam Dodowa, Ghana Filabavi, Vietnam Kanchanaburi, Thailand Karonga, Malawi Kintampo, Ghana Kisumu, Kenya Matlab, Bangladesh Navrongo, Ghana Nouna, Burkina-Faso Vadu, India

History 2010: Consultations in Washington with the Gates sponsored CPTR initiative Critical Path to new TB Regimens to develop TB drug trial capacity within an INDEPTH based platform. 2010: AGM in Accra, agreement to pursue initial cross site activities within two areas: TB risk factors TB suspects

History 2010: Seed money grant from INDEPTH for these two areas Participating sites: Risk factors: Vadu, Karonga, Bandim Suspects: Karonga, KEMRI/CDC, Filabavi, Bandim (not funded)

Preliminary report Funds transferred spring 2011 Field work just initiated Data collection ongoing

TB risk factors - background TB mortality is falling, but still high 1.45 mil. 2010 Important risk factors for TB transmission and mortality well known Some of these currently addressed, eg ART roll out for HIV Other risk factors are thought to be important, but limited data is available.

TB risk factors - background WHO has identified gaps in knowledge: Neglected risk factors (pollution, mental illness, etc) Strength of association for established risk factors consistency, reliability Dose-response relationships (e.g. alcohol, smoking) Effects of cumulative exposure, and ceased exposure Interaction between different risk factors, overlapping exposure / clustering of risk factors Effect modification by setting / epidemiological situation SES gradient in different settings HDSS can provide these data!

TB risk factors - objectives To collect TB burden data on patients residing in the HDSS using the TB registers To collect information on TB risk factors using data collected in the HDSS and link to TB burden and TB treatment outcome data To characterize TB patients who seek (and do not seek) TB care To compare these data across all participating HDSS sites To build capacity in collecting, managing and analyzing tuberculosis surveillance data

TB suspects - background TB diagnosis is difficult Many are suspected of TB - but never diagnosed or treated Case definition for a TB suspect is broad (productive cough > 2 weeks, weight loss) A study from Bandim showed that 4% of assumed TB negative died within one month after initial consultation, 69% of these had TB as primary cause of death on VA

TB suspects - background Through a household visit after one month, 7% of those still symptomatic could be diagnosed with TB. Another study in Zimbabwe showed that 18% of initially smear negative TB patients could be diagnosed with TB within one year of follow-up Follow-up is difficult in routine TB diagnostic facilities HDSS can provide the needed follow-up!

TB suspects - objectives To roll out routines of logging TB suspects in health facility books To ensure HDSS ID is captured for new TB suspects in study area To register clinical symptoms at first presentation To establish follow-up of atbneg 1 month after initial visit at facility To ensure VA of all deceased adults in the study area

TB suspects Current study set up: Doctors enroll TB suspects at regular adult consultations at health centres Prompt HIV testing, x-ray and antibiotic treatment for all smear neg Clinical description Risk assessment with Bandim TBscore

Symptoms Cough Haemoptysis Dyspnoea Chest pain Night sweats Signs Anemia Pulse > 90 beats/min Positive finding at lung auscultation Temperature > 37 (axillary) BMI <18 BMI <16 MUAC <220 mm MUAC <200mm TBscore 14 Wejse C et al. TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis 2008;40(2):111-20.

Status report risk factors Protocol in place Common database under construction Studies conducted: Diabetes prevalence among TB patients and background population (Bandim) Planned risk factor associations to be assessed: Pollution Diabetes Crowding Migration SES Smoking Mental health Site Karonga Vadu Bandim TB patients 45 322 107 Controls - - 700 New pts/year? 106 100

Status report TB suspectss Protocol in place Common database established Patients identified since 2009: Site Karonga Filabavi Kisumu Bandim TB suspects 162 322-506 atbneg 145-470 New pts/year 90 106 100 400

Future plans Enrollment of patients throughout 2012 Additional risk factor association studies to be initiated Abstract presentations at ISC 2012 To expand the network of cross-site TB research To conduct multi-site clinical trials

Focus areas Immediately possible TB suspects Risk factors Treatment delay Health seeking patterns TB cause of death (VA) TB in HIV, ART effects Effects of TB on household health outcomes (eg. Child mortality) Time trends Effects of DOTS Long term goals Compare incidences Risk of poor outcome Prevalence surveys Access to treatment Rural case detection Health care system/staff influence on TBepidemic Multi-site trials: New drugs Vaccine candidates Micronutrients Evaluate new diagnostics Geographical differences

Acknowledgements THANKS to: Sponsors: INDEPTH Network EDCTP Key persons at sites: Rein Houben, Karonga Kayla Laserson, Steve Wandiga, KEMRI/CDC Kisumu Hanif Shaikh, Vadu Hoa Nguyen, Filabavi Frauke Rudolf, Bandim KEMRI/CDC study area Kisumu HDSS, home of Obama s granmother